GlassScriptPhysician profile
Christopher J Cooper
NPI 1689835985
$6,501.97
in general payments reported to CMS, 2019-2025
21 companies · $245 in 2025
The $245 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,404 · 2020: $1,249 · 2021: $14.22 · 2022: $157 · 2023: $223 · 2024: $210 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $471 · Education: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $470.62 |
| Education | $207.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,492.09 | 2019-2025 | |
| Allergan, INC. | $133.18 | 2019-2022 | |
| Kci USA, INC. | $122.42 | 2019-2023 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Integra Lifesciences Corporation | $109.36 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $83.62 | 2019-2023 | Pico 7 |
| Kerecis Limited | $72.91 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Abbvie INC. | $69.04 | 2023-2024 | Strattice Reconstructive Tissue Matrix Bps |
| Ethicon US, LLC | $60.29 | 2023-2025 | Echelon Flex, Echelon; Endopath, Proximate |
| Tela Bio, INC. | $53.87 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Bard Access Systems, INC. | $48.05 | 2019 | |
| Acera Surgical, INC. | $35.82 | 2019-2024 | Restrata Wound Matrix |
| Polynovo North America LLC | $26.76 | 2024 | Novosorb Btm |
| La Jolla Pharmaceutical Company | $25.81 | 2023 | Giapreza |
| Cumberland Pharmaceuticals, INC. | $24.92 | 2019 | |
| Zimmer Biomet Holdings, INC. | $24.07 | 2024 | Advantagerib |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $23.80 | 2019-2020 | |
| Sanara Medtech INC. | $23.00 | 2022 | |
| Solventum Corporation | $22.62 | 2025 | Activ.A.C. |
| Acelrx Pharmaceuticals, INC. | $20.77 | 2019 | |
| Covidien LP | $16.22 | 2020 | |
| Kls-Martin L.P. | $13.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.